Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group

Antimicrob Agents Chemother. 1999 Oct;43(10):2542-6. doi: 10.1128/AAC.43.10.2542.

Abstract

In vitro susceptibilities of 4,208 enterococci (83% Enterococcus faecalis isolates, 13.6% Enterococcus faecium isolates, and 3.4% isolates of other species) from patients in 27 European countries towards 16 antibiotics were determined. High-level resistance to gentamicin varied by country (range, 1 to 49%; mean, 22.6% +/- 12. 3%) and per species (19.7% E. faecalis isolates, 13.6% E. faecium isolates, 3.4% by other species). Vancomycin resistance was detected in 0.06% E. faecalis, 3.8% E. faecium, and 19.1% isolates of other species. All enterococci were susceptible to LY 333328 and everninomicin, and 25% of E. faecalis isolates and 85% of other enterococci were susceptible to quinupristin-dalfopristin. The MIC of moxifloxacin and trovafloxacin for ciprofloxacin-susceptible E. faecalis at which 90% of the isolates were inhibited was 0.25 to 0.5 microg/ml.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Carbapenems / pharmacology
  • Cefpirome
  • Cephalosporins / pharmacology
  • Chloramphenicol / pharmacology
  • Enterococcus faecalis / drug effects*
  • Enterococcus faecium / drug effects*
  • Europe
  • Fluoroquinolones
  • Glycopeptides
  • Gram-Positive Bacterial Infections / microbiology*
  • Humans
  • Microbial Sensitivity Tests
  • Penicillins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Carbapenems
  • Cephalosporins
  • Fluoroquinolones
  • Glycopeptides
  • Penicillins
  • Chloramphenicol